Skip to main content

Series B Pharmaceutical Companies

Explore 58 pharmaceutical startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
58
Total Funding
$1.6B
Avg Funding
$63.8M
Cities
24

Export 58 Series B Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export

NVision Imaging Technologies develops quantum-based medical imaging technology that enhances the capabilities of standard MRI systems.

May 2026
Series B

Founder Contacts

19,000+ verified contacts

Durham, United States

Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.

Apr 2026
Series B

Founder Contacts

19,000+ verified contacts

San Francisco, United States

Spiral Therapeutics is a clinical-stage pharmaceutical company delivering therapies for inner ear disorders.

Apr 2026
Series B

Founder Contacts

19,000+ verified contacts

Illkirch, France
$23.5M
raised

Kainova Therapeutics develops small molecules targeting G-coupled protein receptors.

Feb 2026
Series B

Founder Contacts

19,000+ verified contacts

South San Francisco, United States
$60.0M
raised

BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues

Feb 2026
Series B

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 58 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Seongnam, South Korea
$17.8M
raised

MediMabBio is a biotherapeutic company that focuses on the generation of novel immunotherapies for the treatment of cancer.

Oct 2025
Series B

Founder Contacts

19,000+ verified contacts

Phoenixville, United States
$36.0M
raised

PleoPharma is a pharmaceutical company that focuses on finding treatments for cannabis related health issues.

Oct 2025
Series B

Founder Contacts

19,000+ verified contacts

Waltham, United States
$600.0M
raised

Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.

Oct 2025
Series B

Founder Contacts

19,000+ verified contacts

Portland, United States
$95.0M
raised

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Sep 2025
Series B

Founder Contacts

19,000+ verified contacts

Foster City, United States
$63.0M
raised

AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.

Sep 2025
Series B

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 58 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United Kingdom
$67.5M
raised

NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.

Sep 2025
Series B

Founder Contacts

19,000+ verified contacts

Ghent, Belgium
$64.1M
raised

MRM Health NV is a biopharmaceutical company focused on the discovery and development of therapeutics based on the human microbiome.

Sep 2025
Series B

Founder Contacts

19,000+ verified contacts

Blue Bell, United States
$3.9M
raised

Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.

Aug 2025
Series B

Founder Contacts

19,000+ verified contacts

Cambridge, United States
$132.0M
raised

ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.

Jul 2025
Series B

Founder Contacts

19,000+ verified contacts

Nashville, United States
$30.0M
raised

Technology-driven infusion therapy company

Jun 2025
Series B

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 58 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Barcelona, Spain
$135.0M
raised

Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.

Jun 2025
Series B

Founder Contacts

19,000+ verified contacts

Singapore, Singapore
$45.0M
raised

Nuevocor operates as a preclinical-stage biotech company.

May 2025
Series B

Founder Contacts

19,000+ verified contacts

Vancouver, Canada
$5.0M
raised

Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.

May 2025
Series B

Founder Contacts

19,000+ verified contacts

Lehi, United States
$6.0M
raised

PhotoPharmics is a medical device company that develops treatments for treating neurodegenerative disorders.

Apr 2025
Series B

Founder Contacts

19,000+ verified contacts

Nishiku, Japan
$3.8M
raised

KAICO is a biotechnology company that provides hard-expressing proteins to develop drugs with a silkworm-baculovirus expression system.

Apr 2025
Series B

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 58 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$59.2M
raised

Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.

Apr 2025
Series B

Founder Contacts

19,000+ verified contacts

Stockholm, Sweden
$27.3M
raised

Drug candidates with a unique mechanism of action, aiming to reduce inflammation and pain. Vipoglanstat to enter phase II for endometriosis.

Jan 2025
Series B

Founder Contacts

19,000+ verified contacts

Redwood City, United States
$50.0M
raised

Ashvattha Therapeutics is a clinical-stage biopharmaceutical company that develops precision nanomedicines for ophthalmology diseases.

Jan 2025
Series B

Founder Contacts

19,000+ verified contacts

King Of Prussia, United States
$67.5M
raised

XyloCor Therapeutics is a biopharmaceutical company intended to develop gene therapy for people with coronary artery disease.

Jan 2025
Series B

Founder Contacts

19,000+ verified contacts

Jeonju, South Korea
$2.4M
raised

Kookmin Bio is a biotechnology company that specialises in the development of bio-food and pharmaceutical materials.

Nov 2024
Series B

Founder Contacts

19,000+ verified contacts

Showing 1 to 25 of 58 companies

Ready to Connect with Series B Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 58 series b pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked